BACKGROUND: High density lipoprotein (HDL) plays an important role as an anti-atherogenic molecule, but also possesses anti-inflammatory and anti-angiogenic properties. The effect of extremely low levels of HDL on the risk of sepsis and malignancy were therefore examined. METHODS: A retrospective analysis of patients hospitalized at the Edith Wolfson Medical center was conducted. Patients were divided into Group 1: 108 patients with serum HDL levels < or =20 mg/dl. Group 2: 96 patients with serum HDL levels > or =65 mg/dl. Medical history and laboratory data was recorded. RESULTS: The mean HDL levels in Group 1 were 16.1 +/- 33 mg/dl compared to 74.9 +/- 12.6 mg/dl in Group 2. Using a multivariate logistic regression analysis, low HDL was inversely associated with death (OR 0.96, 95% 0.93-0.99, P = 0.02), 3.98 fold increase in odds of fever (OR 3.98, 95% CI 1.3-11.8, P = 0.01), and 6.7-fold increase in the risk of cancer (OR 6.68, 95% CI 1.8-24.5, P = 0.004). HDL serum levels were inversely associated with sepsis. For each 1 mg/dl increase in HDL, a relative 11% decrease in odds of sepsis was observed (OR 0.886, 95% CI 0.8-0.976, P = 0.01). CONCLUSIONS: Extremely low serum HDL levels (< or =20 mg/dl) are associated with an increased risk of death, sepsis and malignancy.
BACKGROUND: High density lipoprotein (HDL) plays an important role as an anti-atherogenic molecule, but also possesses anti-inflammatory and anti-angiogenic properties. The effect of extremely low levels of HDL on the risk of sepsis and malignancy were therefore examined. METHODS: A retrospective analysis of patients hospitalized at the Edith Wolfson Medical center was conducted. Patients were divided into Group 1: 108 patients with serum HDL levels < or =20 mg/dl. Group 2: 96 patients with serum HDL levels > or =65 mg/dl. Medical history and laboratory data was recorded. RESULTS: The mean HDL levels in Group 1 were 16.1 +/- 33 mg/dl compared to 74.9 +/- 12.6 mg/dl in Group 2. Using a multivariate logistic regression analysis, low HDL was inversely associated with death (OR 0.96, 95% 0.93-0.99, P = 0.02), 3.98 fold increase in odds of fever (OR 3.98, 95% CI 1.3-11.8, P = 0.01), and 6.7-fold increase in the risk of cancer (OR 6.68, 95% CI 1.8-24.5, P = 0.004). HDL serum levels were inversely associated with sepsis. For each 1 mg/dl increase in HDL, a relative 11% decrease in odds of sepsis was observed (OR 0.886, 95% CI 0.8-0.976, P = 0.01). CONCLUSIONS: Extremely low serum HDL levels (< or =20 mg/dl) are associated with an increased risk of death, sepsis and malignancy.
Authors: Anne-Sofie Furberg; Grazyna Jasienska; Nils Bjurstam; Peter A Torjesen; Aina Emaus; Susan F Lipson; Peter T Ellison; Inger Thune Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-01 Impact factor: 4.254
Authors: G W Cockerill; T Y Huehns; A Weerasinghe; C Stocker; P G Lerch; N E Miller; D O Haskard Journal: Circulation Date: 2001-01-02 Impact factor: 29.690
Authors: J L Méndez Mora; M Ortega Calvo; A Cayuela Domínguez; J M Villadiego Sánchez; M M Barros Pérez; J Cantillana Martínez Journal: An Med Interna Date: 2004-05
Authors: G J Molijn; J J Spek; J C van Uffelen; F H de Jong; A O Brinkmann; H A Bruining; S W Lamberts; J W Koper Journal: J Clin Endocrinol Metab Date: 1995-06 Impact factor: 5.958
Authors: Zhenghao Zhang; Geeta Datta; Yun Zhang; Andrew P Miller; Paulina Mochon; Yiu-Fai Chen; John Chatham; G M Anantharamaiah; C Roger White Journal: Am J Physiol Heart Circ Physiol Date: 2009-06-26 Impact factor: 4.733
Authors: Robert Drummond; David M Cauvi; Dennis Hawisher; Donghuan Song; Diego F Niño; Raul Coimbra; Stephen Bickler; Antonio De Maio Journal: Innate Immun Date: 2012-07-02 Impact factor: 2.680
Authors: Edwin O F van Gorselen; Theo Diekman; Jan Hessels; Patrick M J Verhorst; Clemens von Birgelen Journal: Clin Res Cardiol Date: 2010-07-01 Impact factor: 5.460
Authors: F M Shebl; G Andreotti; T E Meyer; Y-T Gao; A Rashid; K Yu; M-C Shen; B-S Wang; T-Q Han; B-H Zhang; F Z Stanczyk; A W Hsing Journal: Br J Cancer Date: 2011-09-13 Impact factor: 7.640